474 related articles for article (PubMed ID: 34597583)
1. Atlas of clinically distinct cell states and ecosystems across human solid tumors.
Luca BA; Steen CB; Matusiak M; Azizi A; Varma S; Zhu C; Przybyl J; Espín-Pérez A; Diehn M; Alizadeh AA; van de Rijn M; Gentles AJ; Newman AM
Cell; 2021 Oct; 184(21):5482-5496.e28. PubMed ID: 34597583
[TBL] [Abstract][Full Text] [Related]
2. Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.
Subramanian A; Nemat-Gorgani N; Ellis-Caleo TJ; van IJzendoorn DGP; Sears TJ; Somani A; Luca BA; Zhou MY; Bradic M; Torres IA; Oladipo E; New C; Kenney DE; Avedian RS; Steffner RJ; Binkley MS; Mohler DG; Tap WD; D'Angelo SP; van de Rijn M; Ganjoo KN; Bui NQ; Charville GW; Newman AM; Moding EJ
Nat Cancer; 2024 Apr; 5(4):642-658. PubMed ID: 38429415
[TBL] [Abstract][Full Text] [Related]
3. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Steen CB; Luca BA; Esfahani MS; Azizi A; Sworder BJ; Nabet BY; Kurtz DM; Liu CL; Khameneh F; Advani RH; Natkunam Y; Myklebust JH; Diehn M; Gentles AJ; Newman AM; Alizadeh AA
Cancer Cell; 2021 Oct; 39(10):1422-1437.e10. PubMed ID: 34597589
[TBL] [Abstract][Full Text] [Related]
4. Profiling Cellular Ecosystems at Single-Cell Resolution and at Scale with EcoTyper.
Steen CB; Luca BA; Alizadeh AA; Gentles AJ; Newman AM
Methods Mol Biol; 2023; 2629():43-71. PubMed ID: 36929073
[TBL] [Abstract][Full Text] [Related]
5. Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types.
Kang J; Lee JH; Cha H; An J; Kwon J; Lee S; Kim S; Baykan MY; Kim SY; An D; Kwon AY; An HJ; Lee SH; Choi JK; Park JE
Nat Commun; 2024 May; 15(1):4067. PubMed ID: 38744958
[TBL] [Abstract][Full Text] [Related]
6. Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.
Steen CB; Liu CL; Alizadeh AA; Newman AM
Methods Mol Biol; 2020; 2117():135-157. PubMed ID: 31960376
[TBL] [Abstract][Full Text] [Related]
7. Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer.
Li S; Pan T; Xu G; Gao Y; Zhang Y; Xu Q; Pan J; Zhou W; Xu J; Li Q; Li Y
Commun Biol; 2023 Jul; 6(1):785. PubMed ID: 37500893
[TBL] [Abstract][Full Text] [Related]
8. Dissecting tumor microenvironment from spatially resolved transcriptomics data by heterogeneous graph learning.
Zuo C; Xia J; Chen L
Nat Commun; 2024 Jun; 15(1):5057. PubMed ID: 38871687
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
[TBL] [Abstract][Full Text] [Related]
10. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
11. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Varn FS; Schaafsma E; Wang Y; Cheng C
Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
[TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
Luo Y; Chen L; Zhou Q; Xiong Y; Wang G; Liu X; Xiao Y; Ju L; Wang X
J Cell Mol Med; 2020 Nov; 24(22):13370-13382. PubMed ID: 33048468
[TBL] [Abstract][Full Text] [Related]
13. Cancer biology deciphered by single-cell transcriptomic sequencing.
Li Y; Jin J; Bai F
Protein Cell; 2022 Mar; 13(3):167-179. PubMed ID: 34405376
[TBL] [Abstract][Full Text] [Related]
14. High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
Theodros D; Murter BM; Sidhom JW; Nirschl TR; Clark DJ; Chen L; Tam AJ; Blosser RL; Schwen ZR; Johnson MH; Pierorazio PM; Zhang H; Ganguly S; Pardoll DM; Zarif JC
Mol Cell Proteomics; 2020 Nov; 19(11):1850-1859. PubMed ID: 32737216
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
[TBL] [Abstract][Full Text] [Related]
16. Conservation of immune gene signatures in solid tumors and prognostic implications.
Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
[TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
18. The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies.
Smith EA; Hodges HC
Trends Cancer; 2019 Jul; 5(7):411-425. PubMed ID: 31311656
[TBL] [Abstract][Full Text] [Related]
19. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments.
Yu JW; Bhattacharya S; Yanamandra N; Kilian D; Shi H; Yadavilli S; Katlinskaya Y; Kaczynski H; Conner M; Benson W; Hahn A; Seestaller-Wehr L; Bi M; Vitali NJ; Tsvetkov L; Halsey W; Hughes A; Traini C; Zhou H; Jing J; Lee T; Figueroa DJ; Brett S; Hopson CB; Smothers JF; Hoos A; Srinivasan R
PLoS One; 2018; 13(11):e0206223. PubMed ID: 30388137
[TBL] [Abstract][Full Text] [Related]
20. Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer.
Huang K; Hu M; Chen J; Wei J; Qin J; Lin S; Du H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
